In this Q&A, Associate Professor Litza Kiropoulos discusses the connection between MS and mental health and her MS Australia-supported research aimed at improving quality of life.
We are deeply saddened to learn that MS South Australia & Northern Territory (MS SA&NT) has entered into voluntary administration.
The McDonald Diagnostic Criteria for MS have been updated to help people get diagnosed faster and more accurately.
Updated international guidelines for diagnosing multiple sclerosis (MS) were published today, enabling earlier and more accurate diagnosis so people can begin treatment sooner and improve their long-term health outcomes.Â
Reporting side effects, even minor ones, is one way people with MS can contribute to safer treatment for everyone.
CEO Rohan Greenland details the upcoming handover of the Blueprint for a National Action Plan for Neurological Conditions, a prod to government to recognise both the obligation and the economic imperative to deliver coordinated national action.
A new Australian study shows COVID-19 boosters improve protection against new variants for people with MS, even when taking immune-suppressing treatments.
People living with MS find MSReactor is a convenient and acceptable way to monitor changes in their thinking and memory over time.
The Pharmaceutical Benefits Advisory Committee has recommended subcutaneous ocrelizumab (Ocrevus®) be listed on the PBS for treating relapsing remitting MS.
